Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention

Best Practice and Research: Clinical Gastroenterology

Volumn 27, Issue 6, 2013, Pages 933-947

  Lansdorp Vogelaar, Iris ^a   Sharp, Linda ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL CANCER REGISTRY IRELAND   (Ireland)

Author keywords

Cost benefit analysis; Early detection of cancer; Helicobacter pylori; Stomach neoplasms

Indexed keywords

ANTIBIOTIC AGENT; CAGA PROTEIN;

ANTIBIOTIC THERAPY; ARTICLE; CANCER PREVENTION; CANCER SCREENING; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEVELOPED COUNTRY; EMBASE; ENDOSCOPY; ERADICATION THERAPY; ETHNIC GROUP; ETHNICITY; HEALTH CARE COST; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; LIFE EXPECTANCY; MASS SCREENING; MEDLINE; PEPTIC ULCER; PHENOTYPE; PREVALENCE; QUALITY ADJUSTED LIFE YEAR; REINFECTION; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STOMACH CANCER; STOMACH ULCER; SYSTEMATIC REVIEW; TREATMENT FAILURE;

EID: 84887137683     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2013.09.005     Document Type: Review

References (49)

1. A. Jemal, F. Bray, M.M. Centre, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin GLOBOCAN 2008 v2.0, cancer incidence and mortality Worldwide: IARC CancerBase No. 10 [Internet] 2010 International Agency for Research on Cancer Available from: http://globocan.iarc.fr/references.htm [accessed 09.09.13]
3. A.C. De Vries, and E.J. Kuipers Review article: helicobacter pylori eradication for the prevention of gastric cancer Aliment Pharmacol Ther 26 Suppl. 2 2007 25 35 (Pubitemid 350233320)
4. P. Correa Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention Cancer Res 52 1992 6735 6740 (Pubitemid 23006271)
5. IARC Infection with Helicobacter pylori IARC Monogr Eval Carcinog Risks Hum 61 1994 177 240
6. Y.C. Lee, J.T. Lin, H.M. Wu, T.Y. Liu, M.F. Yen, and H.M. Chiu Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer Cancer Epidemiol Biomarkers Prev 16 2007 875 885
7. D.Y. Graham, H.M. Malaty, D.G. Evans, D.J. Evans Jr., P.D. Klein, and E. Adam Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status Gastroenterology 100 1991 1495 1501
8. P. Malfertheiner, F. Megraud, C.A. O'Morain, J. Atherton, A.T. Axon, and F. Bazzoli Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report Gut 61 2012 646 664
9. P. Correa, E.T. Fontham, J.C. Bravo, L.E. Bravo, B. Ruiz, and G. Zarama Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy J Natl Cancer Inst 92 2000 1881 1888 (Pubitemid 32036918)
10. W.K. Leung, S.R. Lin, J.Y. Ching, K.F. To, E.K. Ng, and F.K. Chan Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication Gut 53 2004 1244 1249 (Pubitemid 39120105)
11. D. Saito H. pylori infection and gastric cancer: Japanese intervention trial Nihon Rinsho 63 Suppl. 11 2005 35 40
12. W.C. You, L.M. Brown, L. Zhang, J.Y. Li, M.L. Jin, and Y.S. Chang Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions J Natl Cancer Inst 98 2006 974 983 (Pubitemid 44288162)
13. L. Zhou Ten-year follow-up study on the incidence of gastric cancer and the pathological changes of gastric mucosa after H. pylori eradication in China Gastroenterology 134 4 2008 Supplement 1
14. B.C. Wong, S.K. Lam, W.M. Wong, J.S. Chen, T.T. Zheng, and R.E. Feng Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial JAMA 291 2004 187 194 (Pubitemid 38082812)
15. L. Fuccio, R.M. Zagari, M.E. Minardi, and F. Bazzoli Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer Aliment Pharmacol Ther 25 2007 133 141 (Pubitemid 46046370)
16. N.J. Talley, K.M. Fock, and P. Moayyedi Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer Am J Gastroenterol 103 2008 510 514
17. K.M. Fock, N. Talley, P. Moayyedi, R. Hunt, T. Azuma, and K. Sugano Asia-Pacific consensus guidelines on gastric cancer prevention J Gastroenterol Hepatol 23 2008 351 365 (Pubitemid 351342074)
18. J.P. Gisbert, and V. Abraira Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis Am J Gastroenterol 101 2006 848 863
19. J.P. Gisbert, F. de la Morena, and V. Abraira Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis Am J Gastroenterol 101 2006 1921 1930 (Pubitemid 44166605)
20. X.Y. Tian, H. Zhu, J. Zhao, Q. She, and G.X. Zhang Diagnostic performance of urea breath test, rapid urea test, and histology for Helicobacter pylori infection in patients with partial gastrectomy: a meta-analysis J Clin Gastroenterol 46 2012 285 292
21. N. Uemura, T. Mukai, S. Okamoto, S. Yamaguchi, H. Mashiba, and K. Taniyama Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer Cancer Epidemiol Biomarkers Prev 6 1997 639 642 (Pubitemid 27342688)
22. S. Nakagawa, M. Asaka, M. Kato, T. Nakamura, C. Kato, and T. Fujioka Helicobacter pylori eradication and metachronous gastric cancer after endoscopic mucosal resection of early gastric cancer Aliment Pharmacol Ther 24 Suppl. 4 2006 214 218
23. J.Y. Seo, D.H. Lee, Y. Cho, D.H. Lee, H.S. Oh, and H.J. Jo2 Eradication of helicobacter pylori reduces metachronous gastric cancer after endoscopic resection of early gastric cancer Hepatogastroenterology 60 2012 10.5754/hge12929
24. I. Chon, C. Choi, C.M. Shin, Y.S. Park, N. Kim, and D.H. Lee Effect of Helicobacter pylori eradication on subsequent dysplasia development after endoscopic resection of gastric dysplasia Korean J Gastroenterol 61 2013 307 312
25. K. Fukase, M. Kato, S. Kikuchi, K. Inoue, N. Uemura, and S. Okamoto Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial Lancet 372 2008 392 397
26. J. Parsonnet, R.A. Harris, H.M. Hack, and D.K. Owens Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials Lancet 348 1996 150 154 (Pubitemid 26238097)
27. R.A. Harris, D.K. Owens, H. Witherell, and J. Parsonnet Helicobacter pylori and gastric cancer: what are the benefits of screening only for the CagA phenotype of H. pylori? Helicobacter 4 1999 69 76 (Pubitemid 129688331)
28. A.M. Fendrick, M.E. Chernew, R.A. Hirth, B.S. Bloom, R.R. Bandekar, and J.M. Scheiman Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer Arch Intern Med 159 1999 142 148 (Pubitemid 29055101)
29. J. Mason, A.T. Axon, D. Forman, S. Duffett, M. Drummond, and W. Crocombe The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial Aliment Pharmacol Ther 16 2002 559 568 (Pubitemid 34214537)
30. R. Davies, D. Crabbe, P. Roderick, J.R. Goddard, J. Raftery, and P. Patel A simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancers Health Care Manag Sci 5 2002 249 258 (Pubitemid 41450970)
31. P. Roderick, R. Davies, J. Raftery, D. Crabbe, R. Pearce, and P. Bhandari The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model Health Technol Assess 7 2003 1 86
32. P. Roderick, R. Davies, J. Raftery, D. Crabbe, R. Pearce, and P. Patel Cost-effectiveness of population screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation J Med Screen 10 2003 148 156 (Pubitemid 38296852)
33. T. Leivo, A. Salomaa, T.U. Kosunen, R. Tuominen, M. Farkkila, and M. Linna Cost-benefit analysis of Helicobacter pylori screening Health Policy 70 2004 85 96 (Pubitemid 39092961)
34. F. Xie, N. Luo, G. Blackhouse, R. Goeree, and H.P. Lee Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese Int J Technol Assess Health Care 24 2008 87 95 (Pubitemid 351158547)
35. F. Xie, N. Luo, and H.P. Lee Cost effectiveness analysis of population-based serology screening and (13)C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model World J Gastroenterol 14 2008 3021 3027
36. J.M. Yeh, K.M. Kuntz, M. Ezzati, and S.J. Goldie Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results Int J Cancer 124 2009 157 166
37. J.M. Yeh, K.M. Kuntz, M. Ezzati, C. Hur, C.Y. Kong, and S.J. Goldie Development of an empirically calibrated model of gastric cancer in two high-risk countries Cancer Epidemiol Biomarkers Prev 17 2008 1179 1187
38. F. Xie, D. O'Reilly, I.L. Ferrusi, G. Blackhouse, J.M. Bowen, and J.E. Tarride Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada J Am Coll Radiol 6 2009 317 323
39. V. Wiwanitkit Helicobacter pylori screening to prevent gastric cancer: an economical analysis for a tropical developing country Asian Pac J Cancer Prev 11 2010 571 572
40. D.W. Shin, Y.H. Yun, I.J. Choi, E. Koh, and S.M. Park Cost-effectiveness of eradication of Helicobacter pylori in gastric cancer survivors after endoscopic resection of early gastric cancer Helicobacter 14 2009 536 544
41. T. Suzuki, K. Matsuo, A. Sawaki, H. Ito, K. Hirose, and K. Wakai Systematic review and meta-analysis: importance of CagA status for successful eradication of Helicobacter pylori infection Aliment Pharmacol Ther 24 2006 273 280 (Pubitemid 43972895)
42. J.Q. Huang, and R.H. Hunt The evolving epidemiology of Helicobacter pylori infection and gastric cancer Can J Gastroenterol 17 Suppl. B 2003 18B 20B
43. J.M.G. Wilson, and G. Junger Principles and practice of screening for disease 1968
44. D.R. Morgan, J. Torres, R. Sexton, R. Herrero, E. Salazar-Martinez, and E.R. Greenberg Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities JAMA 309 2013 578 586
45. J.P. Gisbert The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review Am J Gastroenterol 100 2005 2083 2099
46. J. Luther, P.D. Higgins, P.S. Schoenfeld, P. Moayyedi, N. Vakil, and W.D. Chey Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: systematic review and meta-analysis of efficacy and tolerability Am J Gastroenterol 105 2010 65 73
47. Y.C. Lee, J.M. Liou, M.S. Wu, C.Y. Wu, and J.T. Lin Eradication of Helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stone Therap Adv Gastroenterol 1 2008 111 120
48. G.H. de Bock, K.M. Vermeulen, L. Jansen, J.C. Oosterwijk, S. Siesling, and M.D. Dorrius Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness Br J Cancer 108 2013 1579 1586
49. E.B. Elkin, D.A. Marshall, N.A. Kulin, I.L. Ferrusi, M.J. Hassett, and U. Ladabaum Economic evaluation of targeted cancer interventions: critical review and recommendations Genet Med 13 2011 853 860